Bibliografía

1. Navarro López F, Paré JC: Infarto agudo de miocardio. En: Navarro López F, Paré JC. Diagnóstico clínico en cardiología. Barcelona, Editorial Médica JIMS, SL 1997; 118-127.

2. Antman E, Braunwald E: Acute myocardial infarction. En: Braunwald E. Heart disease. A text book of cardiovascular medicine, 5th ed. Philadelphia, WB Saunders Co 1997; 1.184-1.288.

3. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, et al: Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861-867.

4. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1999; 326: 242-250.

5. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM et al. ACC/AHA Guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 2000; 28: 1.328-1.428.

6. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348: 771-775.

7. Sharkey SW, Berger CR, Brunette DD, Henry TD. Impact of the electrocardiogram on the delivery of thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1999; 73: 550-553.

8. Arntz HR, Stern R, Linderer T, Schroder R. Efficiency of a physician- operated mobile intensive care unit for prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 1999; 70: 417-420.

9. The European Myocardial Infarction Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993; 329: 383-389.

10. Organización Panamericana de la Salud. Enfermedades cardiovasculares en especial la hipertensión arterial. Washington, D.C.: OPS; 2000.

11. American Heart Association. Heart and stroke facts: 2000 statistical supplement. Dallas, American Heart Association 2000; 1-23.

12. Chambless L, Keil U,Dobson A,Mahonen M, Kuulasmaa K, Rajakangas AM et al. Population versus clinical view of case fatality from acute coronary heart disease :result from the WHO MONICA Project 1985-1990.Multinational MONItoring of Trend and Determinant in Cardiovascular Disease. Ciculation 1997;96 :3.849-3.859.

13. Castiella J, Valdearcos S, Alquezar ML. Análisis de las causas que motivan una excesiva demora prehospitalaria en pacientes con infarto agudo de miocardio en la provincia de Teruel. Rev Esp Cardiol 1997; 50: 860-869.

14. De Vreede JJ, Gorgels AP, Verstraaten GM, Vermeer F, Dassen WR, and Wellens HJ: Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol 2000; 18: 698-706.

15. Hernández Cañero. Morbimortalidad por infarto agudo del miocardio. Rev. Cubana Cardiol Cir. Cardiovasc 2001; 13(1):8-12

16. Vega F LF. Trombolisis Prehospitalaria. Trabajo Para Optar por el Título de Especialista en Cardiología. Medicentro. VC.2001.

17. Cuba. Ministerio de Salud Pública. Informe Estadístico año 2003. Ciudad de la Habana.

18. Iglesias ML, Pedro-Botet J, Hernández E, Solsona JF, Molina L, Álvarez A et al. Tratamiento fibrinolítico en el infarto agudo de miocardio: análisis de los tiempos de demora. Med Clin (Barc) 2000; 106: 281-284.

19. Cuba. Ministerio de Salud Pública. Aplicación de la Estreptoquinasa Recombinante en el infarto Miocárdico Agudo. Extensión nacional. Informe final de ensayo clínico, Ciudad de la Habana, 29 de nov, 1995.

20. Ministerio de Salud y Desarrollo Social. República Bolivariana de Venezuela. Anuario nacional de Estadística. 2003.Tasas.

21. Sánchez GC, Argüelles MT, Vázquez VL, Rosadón CY, Importancia del Tratamiento en Sulfato de Magnesio en pacientes con infarto agudo del miocardio. Estudio preliminar. Rev. Cubana Med 2003; 42(3).

22. Rozman Farreras. Tratado de Medicina Interna Versión electrónica (CD). El infarto agudo del miocardio. 2004. ed. Doyma. Madrid. España.

23. Krumholz HM, Wei JY: Acute myocardial infarction: clinical presentations and diagnosis. En: Gersh BJ, Rahimtoola SH. Acute myocardial infarction. New York, Chapman & Hall 2004; 403-433.

24. Antman EM. ACC/AHA. Guidelines for the management ST elevation Myocardial infarction. Circulation 2004; 110: 588-636.

25. Libby P, Theroux P.Pathophysiology af coronary artery disease Circulation 2005; III: 3481-8.

26. Hillis LD, Lange RA. Myocardial Infarction and the open- Artery Hypothesis.N Engl J Med 2005; 353: 1124-33.

27. Wang K, Asinger RW, Marriot HJL. ST-Segment Elevation in Conditions Other than Acute Myocardial Infarction. N Engl J Med 2003; 349: 2128-34.

28. Gómez PMV, Toledo Queseda A, Castellanos Dumois A, Herrera ML. Trombolisis en el infarto agudo del miocardio. Análisis de los Tiempos de demora. Rev Cubana Med. 2001; 40(2): 91-5.

29. GISSI. Avoidable Delay Study Group: Epidemiology of avoidable delay in the care of patients whit acute myocardial infarction in Italy. Arch Intern Med. 1995; 155:1481.;

30. The GUSTO Argiographic Investigators: the effects of tissue plasminogen activator, Streptokinase or both on coronary-artery potency ventricular function, and survival after acute myocardial infarction. N Engl J Med 1997; 339:1650-2.

31. Collins R, Peto R, Baigent C, Sleight P. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 1997;336:847-60.

32. Valladares Carvajal FJ, Iraola Ferrer MD, Aicto Prendes Pr. Trombolisis Tardía. Rev. Cubana Cardiol Cir Cardiovasc 2000; 14(2): 99-106.

33. Ohman EM, Califf RM, Topol EJ, Candela R, Abbottsmith C, Ellis S, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction: TAMI Study Group.Circulation 1990;82:781-91.

34. No authors listed Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988;2:349-60.

35. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio de lla Streptochinasi nell¥infarto miocardico (GISSI). Lancet 1986;2:397-402.

36. Gosage JR. Acute myocardial infarction: Reperfusion strategies. Chest 1999; 106: 1851- 66.

37. Bradley EH, Herrin J, Wang Y, et al. Strategies for Reducing the Door-to Balloon Time in Acute Myocardial Infarction. N Engl J Med 2006; 355: 2308-

38. Hansson GK. Inflammation, Atheroesclerosis, and Coronary Artery Disease. N Engl J Med 2005; 352: 1685-93.

39. Kolodgie FD, Gold HH. Burke AP, et al. Intraplaque Hemorrhage and Progression of Coronary Atheroma. N Engl J Med 2003; 349: 2316-24.

40. American Heart Association. Cardiovascular disease statisties, 2006. ( AC Cessed December 7, 2006, at http: // w w w. american heart org.)

41. Triolet Gálvez I A, Sánchez MJM Rabell PO, Pino Alvarez AA. Trombolisis en pacientes con Infarto Miocárdico Agudo ingresados en una Unidad de Cuidados Intensivos. Rev cubana Med Intens y Emerg. 2001;1(10): 172-203.

42. Loannidis JP, Salme D, Chew PW, Lam J. Accuracy and Clinical Effect of Out-04-Hospital Electrocardiography in the Diagnosis of Acute Cardiac Ischaemia: A Meta-Analysis. Ann Emerg Med 2001; 37: 461-70.

43. The pre-hospital management of acute heart attacks. Recommendations of a task force of the European Society of Cardiology and the European Resuscitation Council. Eur Heart J 1998; 19: 1.140.

44. Mauro V, Charask A, Gitelman P, Salzberg S, Bruno C, Prieto N y col. Estudio comparativo de la evolución del infarto de miocardio en los últimos 14 años en la Argentina. Conductas terapéuticas. Rev Argent Cardiol 2001; 69:591-601.

45. Spencer B: Acute Myocardial Infarction Are diabetics different? JACC 2000; 35 (3): 1513-5.

46. Cué Brugneran M. Agentes Trombolíticos en el infarto agudo del miocardio. Rev. Cubana de farmacia, Julio-Dic, 1995: p1-12.

47. Piombo A, Salzberg S, Lowenberg T, Grasso C, Finaret B, Golub S y col. Epidemiología del infarto agudo de miocardio en los hospitales públicos de la Capital Federal. Rev Argent Cardiol 1999; 67:201-7.

48. Boletín de Información terapéutica para APS: Boletín No. 10. CDF 1999.

49. Reganon E, Ferrando F, Vila V, Villa P, MartÌnez-Sales V, Fayos L,et al. Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone. Haemostasis 1998;28:99-105.

50. ISIS-2.ISIS-2 (Second International Study of Infarct Survival Collaborative) Group. J Am Coll Cardiol. 1988 Dec;12(6 Suppl A):3A-13A.

51. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.

52. Lee KL; Woodlief JH, Topol EJ. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from a international trial of 41 021 patients. Circulation 2000; 91: 1659-68.

53. White HD, Cross DB, Norris RM. Safety and efficacy of report a trombolitic treatment after acute myocardial infarction. Br Heart J 2000; 64: 174-81.

54. DzariK V, Barton JR, Kee C,Teo KK, Ignaszewski A. Changing practice in the management of acute myocardial infarction complicated by cardiogenic Shock: elderly compared with Younger patients. Can J Cardiol. 1998 Jul; 14 (7 ): 923-30.

55. HeJ, GuD, WuX, et al. Major Causes of Death Among Men and Women in China. N Engl J Med.2005 ;353 ;1124-33.

56. Conti R. Ischemic Heart disease. JACC 2000; 35 (5): 2-3.

57. Liebson PR, Klein LW. The Non Q-wave myocardial infarction revisited: 10 years later. Prog Cardiovasc Dis 2000 mar-apr; 39: 399-444. Camici PG, Crea F. Coronary Microvascular Dysfunction. N Engl J Med 2007; 356:830-8

58. Keeley EC, Hillis D. Primary PCI for Myocardial Infarction with ST segment Elevation. N Engl J Med 2007; 356: 47-52.

59. Gilber WB, Kereiakes DJ, Dean En, Martín L., Anderson L. Prehospital diagnosis and treatment of acute myocardial infarction: A north-south perspective. The Cincinnati heart project and the Nashville prehospital TPA trial. Am Heart J 1999, 121: 1-110.

60. Consejo de Emergencias Cardiovasculares; Sociedad Argentina de CardiologÌa: Primera Encuesta de Unidades Coronarias por Internet. 2002. Comunicación personal.

61. Pfeffer MA, Mc Murray JJV, Velázquez EJ, et al.Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both N Engl J Med 2003; 349: 1893-903.

62. Willich SN, Linderer T, Wegscheider K, Leizorovicz A, Alamercery I, and Schroder R: Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group. Circulation1989; 80: 853-858.

63. Meijer A, Verheugt FW, Werter CJ, Lie KI, van der Pol JM, van Einege MJ, et al. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: A prospective placebo-controlled angiographic study. Results of the APRICOT Study. Circulation 1993;87:1524-30.